Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J McMillan

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Trends in Molecular Medicine|April 13, 2005
Uncovering the mysteries of invasive streptococcal diseasesGursharan S Chhatwal, David J McMillan
Current Opinion in Molecular Therapeutics|March 1, 2005
Prospects for a group A streptococcal vaccineDavid J McMillan, Gursharan S Chhatwal
Frontiers in Microbiology|January 8, 2015
Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilisCelia L McNeilly, David J McMillan
Trends in Microbiology|March 30, 2010
The streptococcal M protein: a highly versatile moleculePierre R Smeesters, David J McMillan, Kadaba S Sriprakash
Plos One|October 19, 2020
In silico characterisation of stand-alone response regulators of Streptococcus pyogenesSean J Buckley, Mark R Davies, David J McMillan
International Journal of Medical Microbiology : IJMM|April 27, 2007
Genetic variation in group A streptococciDavid J McMillan, Kadaba S Sriprakash, Gursharan S Chhatwal
Plos One|June 22, 2018
In silico characterisation of the two-component system regulators of Streptococcus pyogenesSean J Buckley, Peter Timms, Mark R Davies, et al.
FEMS Immunology and Medical Microbiology|March 25, 2004
Immune response to superoxide dismutase in group A streptococcal infectionDavid J McMillan, Mark R Davies, Michael F Good, et al.
Expert Review of Vaccines|June 3, 2009
Moving forward: a mucosal vaccine against group A streptococcusMelina M Georgousakis, David J McMillan, Michael R Batzloff, et al.
Expert Review of Vaccines|November 13, 2009
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Pierre R Smeesters, David J McMillan, Kadaba S Sriprakash, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Trends in Molecular Medicine|April 13, 2005
Uncovering the mysteries of invasive streptococcal diseasesGursharan S Chhatwal, David J McMillan
Current Opinion in Molecular Therapeutics|March 1, 2005
Prospects for a group A streptococcal vaccineDavid J McMillan, Gursharan S Chhatwal
Frontiers in Microbiology|January 8, 2015
Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilisCelia L McNeilly, David J McMillan
Trends in Microbiology|March 30, 2010
The streptococcal M protein: a highly versatile moleculePierre R Smeesters, David J McMillan, Kadaba S Sriprakash
Plos One|October 19, 2020
In silico characterisation of stand-alone response regulators of Streptococcus pyogenesSean J Buckley, Mark R Davies, David J McMillan
International Journal of Medical Microbiology : IJMM|April 27, 2007
Genetic variation in group A streptococciDavid J McMillan, Kadaba S Sriprakash, Gursharan S Chhatwal
Plos One|June 22, 2018
In silico characterisation of the two-component system regulators of Streptococcus pyogenesSean J Buckley, Peter Timms, Mark R Davies, et al.
FEMS Immunology and Medical Microbiology|March 25, 2004
Immune response to superoxide dismutase in group A streptococcal infectionDavid J McMillan, Mark R Davies, Michael F Good, et al.
Expert Review of Vaccines|June 3, 2009
Moving forward: a mucosal vaccine against group A streptococcusMelina M Georgousakis, David J McMillan, Michael R Batzloff, et al.
Expert Review of Vaccines|November 13, 2009
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Pierre R Smeesters, David J McMillan, Kadaba S Sriprakash, et al.
Pageof 6